Todd Christopher Longsworth, General Counsel at NovoCure Ltd (NVCR), sold 5,040 shares at $70.41 ($359K) on 2022-03-04, disclosed to the SEC on 2022-03-07.
Seasonal sale ($359k) by General Counsel — this insider has traded NVCR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.50 | 1,094 | $82K | 22.7% |
| 2 | $70.41 | 1,973 | $139K | 38.7% |
| 3 | $70.41 | 1,973 | $139K | 38.7% |
| Total | $71.30 avg | 5,040 | $359K | 100% |
| Filing → |
| NVCR | SELL | 2021-03-08 | $848K | — | Filing → |
| NVCR | SELL | 2021-03-04 | $716K | — | Filing → |
| NVCR | SELL | 2021-01-19 | $18.5M | — | Filing → |